The DOI matches its Crossref record; the references it cites are not checked yet.
Losartan vs. amlodipine treatment in elderly oncologic hypertensive patients: A randomized clinical trial
Abstract
Elderly neoplastic patients frequently may show hypertension and hyperuricemia, before and after chemotherapeutic treatments. The purpose of this study was to evaluate the efficacy of losartan which is an antihypertensive drug with uricosuric properties vs. amlodipine in hypertensive neoplastic elderly patients. This was an open-labeled, randomized, comparative trial. The study was performed as a 30-day study. Seventy patients with cancer were randomly assigned to receive losartan or amlodipine. Blood pressure (BP), blood urea nitrogen (BUN) levels, creatinine, serum and urinary uric acid, creatinine and uric acid clearance were determined before and after chemotherapy. One day after chemotherapy in losartan group vs. amlodipine group we observed a significant difference in urinary uric acid (p<0.001) of 18 mg/24 h vs. 40 mg/24 h. Thirty days after chemotherapy we observed a significant difference in azotemia of 0.0 mg/dl vs. 3.8 mg/dl (p<0.001), serum uric acid of 0.05 mg/dl vs. 0.49 mg/dl (p<0.001), urinary uric acid (p<0.001) of 23 mg/24 h vs. 0.0 mg/24 h, GFR of 2 ml/min/1.73 m(2) vs. -8 ml/min/1.73 m(2) (p<0.05) and systolic BP (SBP) of 3.6 mmHg vs. 0.8 mmHg (p<0.05). The findings of the present study support the effective role of losartan compared to amlodipine in treating hypertension and hyperuricemia in elderly patients under chemotherapeutic treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists haven’t been fetched yet
References 29 · Cited by 3
Research works printed but not linked: 26
- Baker, 2005, Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?, Am. J. Med., 118, 816, 10.1016/j.amjmed.2005.03.043 · DOI
- Billet, 2008, Role of angiotensin II AT1 receptor activation in cardiovascular diseases, Kidney Int., 74, 1379, 10.1038/ki.2008.358 · DOI
- Blass, 1974, A study of the mechanism of the Jaffè reaction, J. Gun. Chem. Clin. Biochem., 12, 336
- Cammalleri, 2007, Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout, Int. J. Med. Sci., 2, 83, 10.7150/ijms.4.83 · DOI
- Charlson, 1987, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J. Chron. Dis., 40, 373, 10.1016/0021-9681(87)90171-8 · DOI · Paper page
- Di Mauro, 2000, On the importance of multidimensional evaluation of elderly oncologic patients, Arch. Gerontol. Geriatr., 30, 63, 10.1016/S0167-4943(99)00052-7 · DOI
- Di Mauro, 2002, The prevalence of various arrhythmias in normotensive and hypertensive elderly patients, Arch. Gerontol. Geriatr., 35, 227, 10.1016/S0167-4943(02)00031-6 · DOI
- Elliott, 2001, Losartan versus valsartan in the treatment of patients with mild to moderate essential hypertension: data from a multicenter, randomized, double-blind, 12-week trial, Clin. Ther., 23, 1166, 10.1016/S0149-2918(01)80099-0 · DOI
- Enomoto, 2002, Molecular identification of a renal urate anion exchanger that regulates blood urate levels, Nature, 417, 447, 10.1038/nature742 · DOI
- Hamada, 2002, Effect of the angiotensin II receptor antagonist losartan on uric acid and oxypurine metabolism in healthy subjects, Intern. Med., 41, 793, 10.2169/internalmedicine.41.793 · DOI
- Hillebrand, 2002, Influence of antihypertensive drugs on renal microcirculation and renal hemodynamics in cyclosporine A-treated rats, Transplant. Proc., 34, 1383, 10.1016/S0041-1345(02)03068-3 · DOI
- Kurokawa, 2006, Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes: a subanalysis of Japanese patients from the RENAAL study, Clin. Exp. Nephrol., 10, 226, 10.1007/s10157-006-0427-6 · DOI
- Lozano, 2001, Losartan reduces micro-albuninuria in hypertensive microalbuminiruc type 2 diabetic, Nephrol. Dial. Transplant., 16, 85, 10.1093/ndt/16.suppl_1.85 · DOI
- Mackenzie, 1998, Current strategies for retarding the progression of renal disease, Am. J. Kidney Dis., 31, 161, 10.1053/ajkd.1998.v31.pm9428469 · DOI
- Malaguarnera, 2001, Immunosenescence and cancer: a review, Arch. Gerontol. Geriatr., 32, 77, 10.1016/S0167-4943(01)00087-5 · DOI
- Malaguarnera, 2010, The role of immunity in elderly cancer, Crit. Rev. Oncol. Hematol., 74, 40, 10.1016/j.critrevonc.2009.06.002 · DOI
- Malaguarnera, 2000, The comorbidities of elderly oncologic patients, Arch. Gerontol. Geriatr., 30, 237, 10.1016/S0167-4943(00)00050-9 · DOI
- Malaguarnera, 2009, A single dose of rasburicase in elderly patients with hyperuricaemia reduces serum uric acid levels and improves renal function, Expert. Opin. Pharmacother., 10, 737, 10.1517/14656560902781972 · DOI
- Osawa, 2006, Losartan, an angiotensin-II receptor antagonist, retards the progression of advanced renal insufficiency, Tohoku J. Exp. Med., 209, 7, 10.1620/tjem.209.7 · DOI
- Pumo, 2007, Tumor lysis syndrome in elderly, Crit. Rev. Oncol. Hematol., 64, 31, 10.1016/j.critrevonc.2007.05.003 · DOI
- Rampello, 2006, The management of tumor lysis syndrome, Nat. Clin. Pract. Oncol., 3, 438, 10.1038/ncponc0581 · DOI
- Rayner, 2006, Effect of losartan versus candesartan on uric acid, renal function, and fibrinogen in patients with hypertension and hyperuricemia associated with diuretics, Am. J. Hypertens., 19, 208, 10.1016/j.amjhyper.2005.08.005 · DOI
- Repetto, 1998, Performance status and comorbidity in elderly cancer patients compared with young patients with neoplasia and elderly patients without neoplastic conditions, Cancer, 82, 760, 10.1002/(SICI)1097-0142(19980215)82:4<760::AID-CNCR20>3.0.CO;2-V · DOI
- Roch-Ramel, 1997, Effects of uricosuric and antiuricosuric agents on urate transport in human brush-border membrane vesicles, J. Pharmacol. Exp. Ther., 280, 839, 10.1016/S0022-3565(24)36490-0 · DOI
- Shahinfar, 1999, Safety of losartan in hypertensive patients with thiazide-induced hyperuricemia, Kidney Int., 56, 1879, 10.1046/j.1523-1755.1999.00739.x · DOI
- WMAD (World Medical Association Declaration) of Helsinki, 2004, Ethical principles for medical research involving human subjects. WMAD General Assembly, J. Int. Bioethique, 15, 124, 10.3917/jib.151.0124 · DOI
Metadata
- Authors
- Motta, M., Russo, C., Vacante, M., Liardo, R. L. E., Reitano, F., Cammalleri, L., Costanzo, M., Benfatto, G., Frazzetto, P., Mondati, E., Malaguarnera, M., & Pennisi, G.
- Affiliations
- University of Catania (IT)
- Corresponding author
- Malaguarnera, Michele
- ORCID
- Venue
- Archives of Gerontology and Geriatrics
- Publisher
- Elsevier BV
- Published
- 2011-07
- Volume
- 53
- Issue
- 1
- Pages
- 60-63
- ISSN
- 0167-4943 (ISSN-L)
- OpenAlex
- W1994547035
- Cited by
- 3
- References
- 29
- Citations by year
- 2025: 1 · 2015: 2
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Gerontology and Geriatrics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Nephrology › Gout, Hyperuricemia, Uric Acid
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
- Keywords
- losartan, amlodipine, hypertension, hyperuricemia, elderly cancer patients, uricosuric effect, serum uric acid, urinary uric acid, azotemia, glomerular filtration rate, blood pressure
- MeSH terms
- Aged, Antihypertensive Agents, Antineoplastic Agents, Blood Urea Nitrogen, Creatinine, Female, Glomerular Filtration Rate, Humans, Hypertension, Male, Neoplasms, Uric Acid, Geriatric Assessment, Treatment Outcome, Amlodipine, Losartan, Hyperuricemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
